Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 3

Review

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

       
Total article views   HTML views PDF downloads Totals
11,589 Dovepress* 11,589+ 5,105 16,694
Totals 11,589 5,105 16,694
*Since 26 March 2010
+Since July 2016

View citations on Google Scholar